[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Biochemistry and Nutrition in Metabolic Diseases
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 26, Issue 5 (Bimonthly 2022) ::
Feyz 2022, 26(5): 587-594 Back to browse issues page
Investigating of antibiotic resistance in bacteria isolated from the blood of covid-19 patients admitted to the special corona ward of Kosar Semnan Hospital
Majid Eslami , Bahman Yousefi , Majid Mirmohammadkhani , Ali Gohari , Daryoush Pahlevan , Mehdi Dadashpour , Milad Khanzadeh , Parisa Tajdini , Anna Abdolshahi
Department of Nutritional Sciences and Food Technology, Semnan University of Medical Sciences, Semnan, I.R. Iran. , ana.abdoshahi@gmail.com
Abstract:   (994 Views)
Background: More than two years have passed since the epidemic of Covid-19, this disease is still a global crisis. Antibiotic resistance is a global challenge. Therefore, this study aimed to identify and determine the antibiotic resistance of bacteria isolated in the blood samples of patients with Covid-19 hospitalized in the special corona ward of Kosar Semnan Hospital during 2020-2021.
Materials and Methods: The current study is a retrospective cross-sectional descriptive study that was conducted in Semnan. In this study, 22 blood samples with positive bacterial cultures related to patients with Covid-19 were included in the study. The average age of the studied patients was 74.09. 13 patients were male and 9 were female.
Results: Klebsiella was the most common bacteria among the cultured samples. The average length of hospitalization of patients with positive culture Covid-19 was 16.09 days. Antibiogram results showed that among gram-negative bacteria, the highest sensitivity is related to gentamicin, and the highest resistance is related to meropenem, and among gram-positive bacteria, the highest sensitivity is related to oxacillin and coamoxiclav, and the highest resistance is related to meropenem.
Conclusion: Secondary infection caused by bacteria has increased the mortality rate of patients with Covid-19 and antibiotic resistance is high in bacteria isolated from patients with Covid-19.
Keywords: Antibiotic resistance, Covid-19, Secondary infection, Antibiogram, Corona virus
Full-Text [PDF 350 kb]   (556 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2022/09/6 | Revised: 2023/01/25 | Accepted: 2022/11/1 | Published: 2022/12/4
References
1. Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and its inactivation with biocidal agents. J Hospital Infect 2020; 104(3): 246-51.
2. Shakiba M, Nazari SSH, Mehrabian F, Rezvani SM, Ghasempour Z, Heidarzadeh A. Seroprevalence of COVID-19 virus infection in Guilan province, Iran. MedRxiv 2020; 27(2): 636.
3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. New England J Med 2020; 382: 1199-1207.
4. Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19. Jama 2020; 7(11): 549117.
5. Rynda-Apple A, Robinson KM, Alcorn JF. Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease. Infect Immunity 2015; 83(10): 3764-70.
6. Wilson R, Dowling R, Jackson A. The biology of bacterial colonization and invasion of the respiratory mucosa. Eur Respiratory J 1996; 9(7): 1523-30.
7. Paget C, Trottein F. Mechanisms of bacterial superinfection post-influenza: a role for unconventional T cells. Frontiers Immunol 2019; 10: 336.
8. Velavan TP, Meyer CG. The COVID‐19 epidemic. Tropical Med Int Health 2020; 25(3): 278.
9. Agaba P, Tumukunde J, Tindimwebwa J, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes 2017; 10(1): 349.
10. Rawson TM, Moore LS, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, et al. Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 2020; 71(9): 2459-68.
11. Medell M, Medell M, Martinez A, Valdes R. Characterization and sensitivity to antibiotics of bacteria isolated from the lower respiratory tract of ventilated patients hospitalized in intensive care units. Brazilian J Infect Dis 2012; 16(1): 45-51.
12. Hendaus MA, Jomha FA, Alhammadi AH. Virus-induced secondary bacterial infection: a concise review. Therapeutics Clin Risk Manag 2015; 11: 1265.
13. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England J Med 2020; 382: 727-733.
14. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. Jama 2020; 323(8): 709-10.
15. Truog RD, Mitchell C, Daley GQ. The toughest triage—allocating ventilators in a pandemic. New England J Med 2020; 382(21): 1973-5.
16. Hunter DJ. Covid-19 and the stiff upper lip—The pandemic response in the United Kingdom. New England J Med 2020; 382(16): e31.
17. Gautret P, Lagier J-C, Parola P, Meddeb L, Mailhe M, Doudier B, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrobial Agents 2020; 56(1): 105949.
18. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020; 71(15): 769-77.
19. Shenoy S, Taruna Yadav RM. Radhakrishna M. The antibiotic susceptibility patterns of uropathogenic Escherichia coli, with special reference to the fluoroquinolones. J Clin Diagnostic Res 2013; 7(6): 1027.
20. Vellinga A, Tansey S, Hanahoe B, Bennett K, Murphy AW, Cormican M. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. J Antimicrobial Chemotherapy 2012; 67(10): 2523-30.
21. Towns ML, Jarvis WR, Hsueh PR. Guidelines on blood cultures. Journal of Microbiology, Immunol Infect 2010; 43(4): 347-9.
22. Weinstein MP, Lewis JS. The clinical and laboratory standards institute subcommittee on antimicrobial susceptibility testing: background, organization, functions, and processes. J Clin Microbiol 2020; 58(3).
23. Esper FP, Spahlinger T, Zhou L. Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 2011;63(4):260-6.
24. Rice TW, Rubinson L, Uyeki TM, Vaughn FL, John BB, Miller III RR, et al. Critical illness from 2009 pandemic influenza A (H1N1) virus and bacterial co-infection in the United States. Crit Care Med 2012; 40(5): 1487.
25. Ripa M, Galli L, Poli A, Oltolini C, Spagnuolo V, Mastrangelo A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect 2021; 27(3): 451-7.
26. Zhang H, Zhang Y, Wu J, Li Y, Zhou X, Li X, et al. Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect 2020; 9(1): 1958.
27. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. Jama 2020; 323(20): 2085-6.
28. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
29. Goyal P, Choi JJ, Pinheiro LC, Schenck EJ, Chen R, Jabri A, et al. Clinical characteristics of Covid-19 in New York city. New England J Med 2020;382(24):2372-4.
30. Akova M. Epidemiology of antimicrobial resistance in bloodstream infections. Virulence 2016; 7(3): 252-66.
31. Johnson HD, Sholcosky D, Gabello K, Ragni R, Ogonosky N. Sex differences in public restroom handwashing behavior associated with visual behavior prompts. Perceptual Motor Skills 2003; 97(3 Pt 1): 805-10.
32. Sharifipour E, Shams S, Esmkhani M, Khodadadi J, Fotouhi-Ardakani R, Koohpaei A, et al. Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infectious Dis 2020;20(1):1-7.
33. Nori P, Cowman K, Chen V, Bartash R, Szymczak W, Madaline T, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hospital Epidemiol 2021;42(1):84-8.
34. Bhatt PJ, Shiau S, Brunetti L, Xie Y, Solanki K, Khalid S, et al. Risk Factors and Outcomes of Hospitalized Patients With Severe Coronavirus Disease 2019 (COVID-19) and Secondary Bloodstream Infections: A Multicenter Case-Control Study. Clin Infect Dis 2020;72(12):e995-1003.
35. Neill JO. Antimicrobial resistance: tackling a crisis for the health and wealth of nations the review on antimicrobial resistance chaired. Review Paper-Tackling a Crisis for the Health and Wealth of Nations: HM Government Wellcome Trust; 2014. p. 1-20.
36. World Health Organization. Antimicrobial Resistance 2020. Available at: https://www.who.int/ news-room/fact-sheets/detail/antimicrobial-resistance.
37. Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. Jama 2020; 323(15): 1439-40.
38. WHO Director-General’s opening remarks at the media briefing on COVID-19 - 3 March 2020. Available at: https://www.who.int/dg/ speeches/detail/ who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---3-march-2020. Accessed March 13, 2020.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Eslami M, Yousefi B, Mirmohammadkhani M, Gohari A, Pahlevan D, Dadashpour M, et al . Investigating of antibiotic resistance in bacteria isolated from the blood of covid-19 patients admitted to the special corona ward of Kosar Semnan Hospital. Feyz 2022; 26 (5) :587-594
URL: http://feyz.kaums.ac.ir/article-1-4698-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 26, Issue 5 (Bimonthly 2022) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4652